G6PD deficiency is one of the most widespread genetic disorders in the world, affecting over 400 million people, mainly from the Mediterranean basin. Being an X-linked disease, it mainly affects boys, although girls can also be affected (de novo mutations). The WHO has classified the deficiency into 3 classes. Class 2 and 3 deficiencies are characterized by a risk of acute hemolytic shock due to oxidative stress.Outside the acute episode, management is based on preventive measures, avoiding drugs and foods that may precipitate an intravascular hemolysis crisis.
Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno







